awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35163220-6381472D-A20B-4DD2-98D1-E058EF102768
Q35163220-6381472D-A20B-4DD2-98D1-E058EF102768
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35163220-6381472D-A20B-4DD2-98D1-E058EF102768
The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms
P2860
Q35163220-6381472D-A20B-4DD2-98D1-E058EF102768
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35163220-6381472D-A20B-4DD2-98D1-E058EF102768
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fde2b7e5084879838072119569a74e6e8571dbf0
P2860
CD52 expression in non-mycotic T- and NK/T-cell lymphomas.